Business

BeautyHealth’s SkinStylus™ Receives New FDA Clearance for Facial Acne Scarring

Now the only microneedling device FDA-cleared for use on both the face and abdomen Milestone achievement in just five months since BeautyHealth’s acquisition

articleSkinhealth Systems Inc.August 2, 20234/company/beauty-health-co/news/beautyhealths-skinstylustm-receives-new-fda-clearance-for-facial-acne-scarring
BeautyHealth’s SkinStylus™ Receives New FDA Clearance for Facial Acne Scarring

About this update from Skinhealth Systems Inc.

[{"type":"text","content":"\nNow the only microneedling device FDA-cleared for use on both the face and abdomen\nMilestone achievement in just five months since BeautyHealth’s acquisition of the brand\n\n\n LONG BEACH, Calif.--(BUSINESS WIRE)--\nThe Beauty Health Company (NASDAQ:SKIN), home to hero brand Hydrafacial, today announced the U.S. Food and Drug Administration (FDA) has cleared its SkinStylus™ microneedling device for use on facial acne scarring in Fitzpatrick skin types I, II, and III in patients aged 22 years and older, making it the only microneedling device FDA cleared for both the face and abdomen.\n\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230802207816/en/SkinStylus™ (Photo: Business Wire)\nThe clearance from the FDA is a notable milestone for SkinStylus™ since its acquisition by BeautyHealth in February of this year, revealing of an ambitious and accelerated path for the brand since coming under BeautyHealth’s leadership.\n\n\n“SkinStylus’ new facial indication for acne scarring is a testament to BeautyHealth’s innovation track record, proven brand building expertise, and our commitment to creating the future of skin health,” said BeautyHealth President and Chief Executive Officer Andrew Stanleick. “Our goal is to become the world’s leading beauty, health and wellness platform by bringing together incredible brands and growing them into category leaders. This SkinStylus indication further unlocks the potential of the highly complementary treatments in our multi-brand ecosystem and positions SkinStylus for exponential growth in the years ahead.”\n\n\nExpected to reach $1 billion U.S. market size by 20301, microneedling is a minimally invasive treatment that is quickly becoming a favorite amongst providers and skincare lovers. Google searches for microneedling are up +20% YoY and up +88% from five years ago2; and the hashtag term #microneedling has over 4.4 million uses on Instagram3.\n\n\nMicroneedling uses small needles to create tiny, controlled micro injuries that help trigger collagen and elastin production, which is essential for smoother, firmer, and more even-toned skin.\n\n\nSkinStylus™ is an esthetician-founded brand, and the SkinStylus™ SteriLock® MicroSystem is designed to fit into the way medical and aesthetic professionals work, with a combined feature set th...

More updates from Skinhealth Systems Inc.